Evolus Inc banner

Evolus Inc
NASDAQ:EOLS

Watchlist Manager
Evolus Inc Logo
Evolus Inc
NASDAQ:EOLS
Watchlist
Price: 4.32 USD 0.47%
Market Cap: $280m

Profitability Summary

Evolus Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Evolus Inc

Margins Comparison
Evolus Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Evolus Inc
NASDAQ:EOLS
278.5m USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
970.2B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
596.3B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
288.1B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
250B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
237.1B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
300.1B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
155.3B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Evolus Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Evolus Inc
NASDAQ:EOLS
278.5m USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
970.2B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
596.3B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
288.1B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
250B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
237.1B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
300.1B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
155.3B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Evolus Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett